Prof. Van Dongen contributed to ~700 manuscripts and book chapters, including ~450 SCI publications (with ~26,000 citations, ~59 citations per paper and h-index of 86). He is inventor on 18 patent (applications): 14/18 granted; all licensed. He coordinates or coordinated 7 European networks in the field of diagnostics in hemato-oncology and immunology, including 4 EU-supported consortia. Three of these EU-supported consortia obtained long-term sustainability based on revenues from collectively filed and owned patents. He is the founding chairman of these three consortia, EuroClonality (1996-2011), EuroMRD (2001-2017) and EuroFlow (2006-now), which are united in the European Scientific foundation of Laboratory Hemato-Oncology (ESLHO).